Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Journal of Affective Disorders
|
September 7, 2022
Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study
Melody J Y Kang, Gustavo H Vazquez
The Psychiatric Clinics of North America
|
February 4, 2020
Suicidal Behavior Associated with Mixed Features in Major Mood Disorders
Leonardo Tondo, Gustavo H Vazquez, Ross J Baldessarini
Journal of Affective Disorders
|
January 8, 2021
Response to commentary on the comparative efficacy of esketamine vs. ketamine meta-analysis: Putting the cart before the horse?
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
Journal of Affective Disorders
|
October 6, 2020
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
Journal of Affective Disorders
|
November 24, 2020
Erratum to "Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis" [Journal of Affective Disorders 278C (2021) 542-555]
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
Frontiers in Psychiatry
|
March 18, 2024
Editorial: Old treatments new outcomes-augmentation treatments for depression
Nicolas A Nuñez, Boney Joseph, Gustavo H Vazquez
Expert Opinion on Drug Safety
|
March 1, 2022
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Anees Bahji, Carlos A Zarate, Gustavo H Vazquez
Journal of Affective Disorders
|
December 27, 2022
Response to "Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis."
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
The International Journal of Neuropsychopharmacology
|
April 30, 2021
Ketamine for Bipolar Depression: A Systematic Review
Anees Bahji, Carlos A Zarate, Gustavo H Vazquez
CNS & Neurological Disorders Drug Targets
|
August 1, 2017
Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics
Gustavo H Vazquez, Sebastian Camino, Leonardo Tondo, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Journal of Affective Disorders
|
September 7, 2022
Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study
Melody J Y Kang, Gustavo H Vazquez
The Psychiatric Clinics of North America
|
February 4, 2020
Suicidal Behavior Associated with Mixed Features in Major Mood Disorders
Leonardo Tondo, Gustavo H Vazquez, Ross J Baldessarini
Journal of Affective Disorders
|
January 8, 2021
Response to commentary on the comparative efficacy of esketamine vs. ketamine meta-analysis: Putting the cart before the horse?
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
Journal of Affective Disorders
|
October 6, 2020
Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
Journal of Affective Disorders
|
November 24, 2020
Erratum to "Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis" [Journal of Affective Disorders 278C (2021) 542-555]
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
Frontiers in Psychiatry
|
March 18, 2024
Editorial: Old treatments new outcomes-augmentation treatments for depression
Nicolas A Nuñez, Boney Joseph, Gustavo H Vazquez
Expert Opinion on Drug Safety
|
March 1, 2022
Efficacy and safety of racemic ketamine and esketamine for depression: a systematic review and meta-analysis
Anees Bahji, Carlos A Zarate, Gustavo H Vazquez
Journal of Affective Disorders
|
December 27, 2022
Response to "Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis."
Anees Bahji, Gustavo H Vazquez, Carlos A Zarate
The International Journal of Neuropsychopharmacology
|
April 30, 2021
Ketamine for Bipolar Depression: A Systematic Review
Anees Bahji, Carlos A Zarate, Gustavo H Vazquez
CNS & Neurological Disorders Drug Targets
|
August 1, 2017
Potential Novel Treatments for Bipolar Depression: Ketamine, Fatty Acids, Anti-inflammatory Agents, and Probiotics
Gustavo H Vazquez, Sebastian Camino, Leonardo Tondo, et al.
Page
of 3